Published in J Pharmacol Exp Ther on February 01, 2000
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest (2011) 4.21
Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res (2006) 3.43
Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Res (2008) 1.98
Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest (2011) 1.54
RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc Natl Acad Sci U S A (2012) 1.40
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer. World J Urol (2005) 1.12
Current progress on aptamer-targeted oligonucleotide therapeutics. Ther Deliv (2013) 1.09
Sequence-dependent cytotoxicity of second-generation oligonucleotides. Nucleic Acids Res (2004) 0.95
Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucleic Acids Res (2004) 0.94
Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding. Int Immunol (2011) 0.94
Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel. J Exp Clin Cancer Res (2011) 0.91
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern. Nucleic Acid Ther (2013) 0.91
Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals. Mol Ther Nucleic Acids (2012) 0.86
MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.86
Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells. Nucleic Acids Res (2001) 0.86
Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front Chem (2014) 0.84
Toxicological and pharmacokinetic properties of chemically modified siRNAs targeting p53 RNA following intravenous administration. Nucleic Acid Ther (2012) 0.83
Potential use of custirsen to treat prostate cancer. Onco Targets Ther (2013) 0.78
Impact of dosing regimen of custirsen, an antisense oligonucleotide, on safety, tolerability and cardiac repolarization in healthy subjects. Br J Clin Pharmacol (2015) 0.78
Enzymatic synthesis of modified oligonucleotides by PEAR using Phusion and KOD DNA polymerases. Nucleic Acid Ther (2014) 0.75
A population pharmacokinetic meta-analysis of custirsen, an antisense oligonucleotide, in oncology patients and healthy subjects. Br J Clin Pharmacol (2017) 0.75
The CATH database: an extended protein family resource for structural and functional genomics. Nucleic Acids Res (2003) 8.36
Regulation of the bacterial cell wall: analysis of a mutant of Bacillus subtilis defective in biosynthesis of teichoic acid. J Bacteriol (1972) 5.55
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin (2001) 4.41
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol (1999) 4.11
Asia Pacific consensus recommendations for colorectal cancer screening. Gut (2008) 3.19
A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest (2001) 3.18
Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem (1991) 2.65
In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria. Antimicrob Agents Chemother (2000) 2.39
Unique checkpoints during the first cell cycle of fertilization after intracytoplasmic sperm injection in rhesus monkeys. Nat Med (1999) 2.30
Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage (1997) 2.29
Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ (1993) 2.24
Pathogenesis of the urethral syndrome in women and its diagnosis in general practice. Lancet (1972) 2.21
Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem (1994) 2.00
Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest (1996) 1.76
The management of suspected urinary tract infection in general practice. Br J Gen Pract (1990) 1.76
Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev (2005) 1.69
Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J Invest Dermatol (1994) 1.63
Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol (1996) 1.60
Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci (1989) 1.60
Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest (1999) 1.59
Towards the reality of the primary health care team: an educational approach. J R Coll Gen Pract (1981) 1.57
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia (2002) 1.54
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Taxonomy and phylogeny of industrial solvent-producing clostridia. Int J Syst Bacteriol (1995) 1.48
Symptomatic urinary infection in childhood: presentation during a four-year study in general practice and significance and outcome at seven years. J R Coll Gen Pract (1977) 1.47
Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat Biotechnol (2000) 1.43
Should the endurance shuttle walk test replace the six-minute walk test in individuals with chronic obstructive pulmonary disease? Chron Respir Dis (2006) 1.41
Internal fixation of wrist fractures. J R Soc Med (1978) 1.39
Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol (2000) 1.39
Statement on withholding and withdrawing life-sustaining therapy. S Afr Med J (1994) 1.38
Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest (1996) 1.38
Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J Pharmacol Exp Ther (1996) 1.38
An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther (1997) 1.34
In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells. Nucleic Acids Res (1997) 1.28
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology (1998) 1.28
Who uses the Smoker's Quitline in Massachusetts? Tob Control (2002) 1.27
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol (2001) 1.27
Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (2000) 1.25
Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab Invest (1997) 1.25
Pressure-volume index in head injury. J Neurosurg (1987) 1.23
Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res (1998) 1.22
Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol (1985) (1995) 1.18
Nutritional support for individuals with COPD: a meta-analysis. Chest (2000) 1.16
Impairments in balance discriminate fallers from non-fallers in COPD. Respir Med (2009) 1.14
Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B. J Biol Chem (1991) 1.13
A lipid intermediate in the synthesis of a poly-(N-acetylglucosamine 1-phosphate) from the wall of Staphylococcus lactis N.C.T.C. 2102. Biochem J (1969) 1.12
A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci (2001) 1.12
Nonhistone protein BA is a glutathione S-transferase localized to interchromatinic regions of the cell nucleus. J Cell Biol (1986) 1.12
Direction of chain extension during the biosynthesis of teichoic acids in bacterial cell walls. Nature (1969) 1.12
ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Antisense Nucleic Acid Drug Dev (2001) 1.11
The mechanism of biosynthesis and direction of chain extension of a poly-(N-acetylglucosamine 1-phosphate) from the walls of Staphylococcus lactis N.C.T.C. 2102. Biochem J (1969) 1.10
Glucosylation of teichoic acid: solubilization and partial characterization of the uridine diphosphoglucose: polyglycerolteichoic acid glucosyl transferase from membranes of Bacillus subtilis. J Bacteriol (1971) 1.10
Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp Cell Res (1994) 1.09
Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 1.06
Role of endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis in patients undergoing laparoscopic cholecystectomy. Gastrointest Endosc (1998) 1.06
Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol (1994) 1.05
Perspectives that influence action plans for chronic obstructive pulmonary disease. Can Respir J (2006) 1.04
Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice. J R Coll Gen Pract (1972) 1.04
Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice. J Pharmacol Exp Ther (2000) 1.04
A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem (2001) 1.04
Electrokinetic and electrostatic properties of bilayers containing gangliosides GM1, GD1a, or GT1. Comparison with a nonlinear theory. Biophys J (1986) 1.03
Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med (1999) 1.03
The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J Biol Chem (1999) 1.02
Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des (1997) 1.01
Mechanism of phorbol ester inhibition of histamine-induced IP3 formation in cultured airway smooth muscle. Am J Physiol (1989) 1.01
Enzyme immunoassay for surveillance of Q fever. Am J Vet Res (1985) 1.01
Islet-activating protein inhibits leukotriene D4- and leukotriene C4- but not bradykinin- or calcium ionophore-induced prostacyclin synthesis in bovine endothelial cells. Proc Natl Acad Sci U S A (1986) 1.00
PET: its clinical role in neurology. J Neurol Neurosurg Psychiatry (1991) 0.98
Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract (2014) 0.96
Patterns of self-harm behavior among women with borderline personality symptomatology: psychiatric versus primary care samples. Gen Hosp Psychiatry (2000) 0.96
Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies. Mol Biol Cell (1998) 0.96
Ventilatory and arousal responses to hypoxia and hypercapnia in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med (1997) 0.96
In vitro investigation of autoantibody-secreting peritoneal cells and their regulation. Immunology (1979) 0.96
The reactivity of a monoclonal antibody against cells of the monocyte-macrophage series in sections of normal and inflamed human tissues. J Reticuloendothel Soc (1983) 0.96
Fully modified 2' MOE oligonucleotides redirect polyadenylation. Nucleic Acids Res (2001) 0.96
Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther (2001) 0.96
Critical appraisal of clinical practice guidelines targeting chronic obstructive pulmonary disease. Arch Intern Med (2001) 0.95
Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 0.95
Respiratory-related heart rate variability persists during central apnea in dogs: mechanisms and implications. J Appl Physiol (1985) (1995) 0.95
The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest (1998) 0.95
Chest physical therapy management of patients with cystic fibrosis. A meta-analysis. Am J Respir Crit Care Med (1995) 0.95
Eosinophilic cholangiopathy. Gastrointest Endosc (1997) 0.95
Race and child welfare services: past research and future directions. Child Welfare (1997) 0.95
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia (2004) 0.95
Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis (1998) 0.94
The identification of lymphoid cell subpopulations in sections of human lymphoid tissue and gingivitis in children using monoclonal antibodies. J Periodontal Res (1982) 0.94
Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia (2000) 0.93
Factors associated with smoking among children and adolescents in Connecticut. Am J Prev Med (1998) 0.93
Externalizing symptomatology among adoptive youth: prevalence and preadoption risk factors. J Abnorm Child Psychol (2001) 0.93
Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells. J Biol Chem (1996) 0.93
The effect of circumferential taping on flexor tendon pulley failure in rock climbers. Am J Sports Med (2001) 0.92
Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Gene Ther (2003) 0.92
A demonstration project of a multi-component educational intervention to improve integrated post-fracture osteoporosis care in five rural communities in Ontario, Canada. Osteoporos Int (2008) 0.92
Vertical organization in the visual cortex (area 17) in the cat. Exp Brain Res (1974) 0.91